BridgeBio Oncology Therapeutics Statistics

NASDAQ: BBOTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.44-0.06 (-1.71%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 3.44 0.00%

BridgeBio Oncology Therapeutics by the numbers

BridgeBio Oncology Therapeutics has a market capitalization of $275.8 million based on 80.17M shares outstanding. With trailing EPS of $-0.07, BridgeBio Oncology Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 52.0% below its 50-day average and 61.7% below its 200-day average.

Average daily trading volume is 475.11K shares, or about $1.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BBOT valuation vs. peer median

BBOT compared with the median of 8 peer companies
Metric	BBOT	Peer median	Difference
Market cap	$275.80M	$280.41M	-2%
Avg. volume	475.11K	1.38M	-65%

Peer median across 8 companies: CATX, FULC, RCKT, VNDA, LRMR, BIOA, ABEO, BCYC.

Valuation

Market cap: $275.80M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-0.07
Shares outstanding: 80.17M

Price and trading

Previous close: 3.50
Open: 3.46
Day range: 3.36 – 3.57
52-week range: 3.36 – 14.87
52-week change: -71.83%
50-day moving average: 7.16
200-day moving average: 8.98
Beta: —
Volume: 321.31K
Average volume: 475.11K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 11, 2026

Additional statistics

Market Cap: 275.80M
Forward Pe: -1.27
Eps: -0.07
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 14.87
Week52 Low: 3.36
Avg Volume: 475.11K
Shares Outstanding: 80.17M
Ma50: 7.16
Ma200: 8.98
Earnings Date: Nov 11, 2026
Pct From52w High: -76.87%
Pct From52w Low: 2.38%